概要
プログラム委員会
-
Mingqiang Zhang General Manager, Corporate VP of R&D
Amgen BioPharmaceutical R&D (Shanghai) Co., Ltd, China -
Zaiqi Wang, MD, PHD CEO
InxMed, China -
Steve Yang, PHD Executive Vice President and Chief Operational Officer
Wuxi Pharma Tech Inc., China -
Weikang Tao Vice President of Corporation, CEO of R&D Centers
Jiangsu Hengrui Medicine Co., Ltd., China -
Kelly Dong CEO
UP Pharma, China -
Qing-Shan Zheng, MD, PHD Director, Center for Drug Clinical Research
Shanghai University of Chinese Medicine, China -
Xiaojun (Wendy) Yan, MD, MBA Strategic Advisor
DIA BOD, China -
Jingsong Wang, MD Founder, Chairman, and Chief Executive Officer
Harbour BioMed, China -
Chenbing Wu Founder and Chief Executive Officer
Epimab Biotherapeutics Inc., China -
Jimmy Zhang Vice President, Transactions Asia Pacific Innovation Center
Johnson & Johnson, China -
Carol Zhu, MBA Vice President, Portfolio and Project Management
JW Therapeutics, China
